Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07401940Not ApplicableRecruiting

HAVEN-Connect Youth Suicide Prevention

Role: collaborator

NCT06006637Not ApplicableRecruiting

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Role: collaborator

NCT03721679Phase 1Terminated

Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1

Role: collaborator

All 3 trials loaded